Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection

by Balakrishnan, Thavamalar, Bela-ong, Dennis B., Toh, Ying Xiu, Flamand, Marie, Devi, Shamala, Koh, Mickey B., Hibberd, Martin L., Ooi, Eng Eong, Low, Jenny G., Leo, Yee Sin, Gu, Feng, Fink, Katja
Published 2011

Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma (NPC).

by Walsh, Robert John, Nickles, Emily Pauline, Li, Yating, Dharmadhikari, Bhushan, Koh, Mickey, Ho, Liam Pock, Chan, Marieta, Koh, Liang Piu, Poon, Michelle Li Mei, Tan, Lip Kun, Huang, Yiqing, Ang, Yvonne Li'en, Chong, Wan Qin, Asokumaran, Yugarajah, Loh, Kwok Seng, Soo, Ross A, Lim, Chwee Ming, Schwarz, Herbert, Goh, Boon Cher
Published 2023

Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit

by Nickles, Emily, Dharmadhikari, Bhushan, Li, Yating, Walsh, Robert J, Koh, Liang Piu, Poon, Michelle, Tan, Lip Kun, Wang, Ling-Zhi, Ang, Yvonne, Asokumaran, Yugarajah, Chong, Wan Qin, Huang, Yiqing, Loh, Kwok Seng, Tay, Joshua, Soo, Ross, Koh, Mickey, Ho, Liam Pock, Chan, Marieta, Niam, Madelaine, Soh, Melissa, Luah, Yen Hoon, Lim, Chwee Ming, Kaliaperumal, Nivashini, Au, Veonice B, Talib, Najwa Binte Said Nasir, Sng, Reina, Connolly, John E, Goh, Boon Cher, Schwarz, Herbert
Published 2023